Chris Mutz
Head of Rare Disease at ANI Pharmaceuticals, Inc. | Greater Boston, United States
Chris Mutz’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Head of Rare Disease at ANI Pharmaceuticals, Inc. in February 2021 - Present
Founder/Consultant at Galinia Bioventures in May 2019 - February 2021
Vice President - U.S. Neurology Business Unit Leader at Alexion Pharmaceuticals, Inc. in March 2018 - April 2019
Vice President - U.S. Metabolic Business Unit Leader at Alexion Pharmaceuticals, Inc. in January 2017 - March 2018
Executive Sales Director, U.S. Metabolic Business Unit at Alexion Pharmaceuticals, Inc. in August 2015 - December 2016
Executive Director, U.S. Marketing - aHUS at Alexion Pharmaceuticals, Inc. in July 2013 - August 2015
Senior Director, U.S. Marketing - Hematology at Alexion Pharmaceuticals, Inc. in November 2011 - July 2013
Senior Director, U.S. Marketing Leader - Merck Oncology at Merck in October 2009 - October 2011
MSD China - Global Marketing Leadership Assignment at Merck in September 2010 - September 2011
Global Marketing Leader, New Products - Merck Oncology at Merck in October 2008 - September 2009
U.S. Marketing Leader, New Products - Merck Oncology at Merck in August 2007 - October 2008
Senior Marketing Manager - Merck Oncology at Merck in January 2006 - August 2007
Promotion Manager - Cardiovascular at Merck in July 2004 - December 2005
Marketing Analyst - U.S. Pharmaceuticals at Merck in August 2001 - June 2004
University of Virginia
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit https://www.anipharmaceuticals.com/.
Discover more about ANI Pharmaceuticals, Inc.
Northeast Area Business Director
Executive HIV Prevention Specialist - Regional Trainer at Gilead Sciences
(August 2026 – August 2026)
9x Presidents Club Winner * Rheumatology * Neurology * Nephrology * Immunotherapy * Buy & Bill * Rare Disease * Biotechnology
Clinical Account Executive at ANI Pharmaceuticals, Inc.
(February 2024 – Present)
Pharmaceutical Professional with 35+ Years of Experience
Data Reviewer, Quality Assurance and Compliance at ANI Pharmaceuticals, Inc.
(August 2018 – March 2023)
Vice President - Head of Supply Chain at ANI Pharmaceuticals
Head of Supply Chain at Cipla
(August 2026 – August 2026)
Rare Disease Clinical Account Executive
Clinical Account Executive at ANI Pharmaceuticals, Inc.
(January 2022 – Present)
Rare Disease | Sales Executive | Sales Trainer | Product Launches | Start-up Biopharma | Award Winning | Field Access Expert | Specialty Pharmacy | HUB Management
Executive Renal Sales Specialist at ZS PharmaAstra Zeneca LP Us
(August 2026 – August 2026)
What is Chris Mutz email address?
Email Chris Mutz at [email protected] and [email protected]. This email is the most updated Chris Mutz's email found in 2026.
How to contact Chris Mutz?
To contact Chris Mutz send an email to [email protected] or [email protected].
What company does Chris Mutz work for?
Chris Mutz works for ANI Pharmaceuticals, Inc..
What is Chris Mutz's role at ANI Pharmaceuticals, Inc.?
Chris Mutz is Head of Rare Disease
What industry does Chris Mutz work in?
Chris Mutz works in the Biotechnology industry.
